These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 18223207)
1. Role of IG20 splice variants in TRAIL resistance. Prabhakar BS; Mulherkar N; Prasad KV Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207 [TBL] [Abstract][Full Text] [Related]
2. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Ramaswamy M; Efimova EV; Martinez O; Mulherkar NU; Singh SP; Prabhakar BS Oncogene; 2004 Aug; 23(36):6083-94. PubMed ID: 15208670 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L; Fang B Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937 [TBL] [Abstract][Full Text] [Related]
4. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells. Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419 [TBL] [Abstract][Full Text] [Related]
6. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684 [TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600 [TBL] [Abstract][Full Text] [Related]
8. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244 [TBL] [Abstract][Full Text] [Related]
9. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688 [TBL] [Abstract][Full Text] [Related]
11. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Wang P; Song JH; Song DK; Zhang J; Hao C Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262 [TBL] [Abstract][Full Text] [Related]
12. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells. Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463 [TBL] [Abstract][Full Text] [Related]
13. Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells. Hwang MK; Min YK; Kim SH Biochem Cell Biol; 2009 Dec; 87(6):919-26. PubMed ID: 19935877 [TBL] [Abstract][Full Text] [Related]
14. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5. Gasparian ME; Chernyak BV; Dolgikh DA; Yagolovich AV; Popova EN; Sycheva AM; Moshkovskii SA; Kirpichnikov MP Apoptosis; 2009 Jun; 14(6):778-87. PubMed ID: 19412666 [TBL] [Abstract][Full Text] [Related]
15. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L). Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339 [TBL] [Abstract][Full Text] [Related]
16. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Zhang Y; Zhang B Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831 [TBL] [Abstract][Full Text] [Related]
17. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022 [TBL] [Abstract][Full Text] [Related]
19. Modulation of TRAIL signaling for cancer therapy. Fulda S; Debatin KM Vitam Horm; 2004; 67():275-90. PubMed ID: 15110182 [TBL] [Abstract][Full Text] [Related]
20. Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition. Morales JC; Ruiz-Magaña MJ; Ruiz-Ruiz C Mol Immunol; 2007 Apr; 44(10):2587-97. PubMed ID: 17257681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]